Delivery Order SPE2DB25D7068-SPE2DB25FTXJA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count) in a firm fixed price contract valued at $1,083.96, with an ultimate completion date of September 4, 2025. This non-set-aside competitive award was issued on September 3, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100 count) valued at $4,175.73 on August 11, 2025, with completion targeted for August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The products will be performed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,773.94 to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100 count) on July 23, 2025, with completion scheduled for July 24, 2025. This competitive, non-set-aside award represents a firm fixed-price delivery order fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The contract was issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $3,612.72 to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count supply) on July 14, 2025, with completion targeted for July 15, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract under the company's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,387.40 to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 10mg tablets (100 count) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Methylphenidate is a central nervous system stimulant commonly used in military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,043.04 to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100 count) on July 22, 2025, with a completion date of July 23, 2025. This non-set-aside, firm fixed price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate ER 27 mg, a controlled-release medication used to treat attention-deficit/hyperactivity disorder. This firm fixed-price delivery order, valued at $1,512.22, represents a non-set-aside, competitively awarded contract with an ultimate completion date of August 12, 2025. The order was fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100-count) with a ceiling value of $1,298.32. This competitively awarded, firm fixed-price contract was executed on August 6, 2025, with an ultimate completion date of August 7, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, which serves as the company's corporate headquarters and primary distribution hub for federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,630.67 to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100-count containers) with an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100 count) with a ceiling value of $14,844.56 under a firm fixed-price contract structure. The award was issued on June 30, 2025, with an ultimate completion date of July 1, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. This...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTXJADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100-count) with a ceiling value of $2,421.45. This non-set-aside, firm fixed-price delivery order was awarded on July 24, 2025, with an ultimate completion date of July 25, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and other government healthcare systems. The company's extensive federal contract portfolio demonstrates proven capability to meet military and veteran healthcare pharmaceutical needs through competitive procurement processes. Methylphenidate, a controlled-release ADHD medication, represents the type of specialty pharmaceutical product the company routinely supplies to support military medical operations worldwide under its DLA prime vendor agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/24/25 |